DASHTAG

00090627
Active Cramlington

Activities of head offices

0 employees website.com
Activities of head offices
D

DASHTAG

00090627

Activities of head offices

Founded 31 Oct 1906 Active Cramlington, United Kingdom 0 employees website.com
Activities of head offices

Previous Company Names

SCHERING-PLOUGH HOLDINGS LIMITED 31 Dec 1980 — 28 Jul 1989
C.E.FULFORD LIMITED 31 Oct 1906 — 31 Dec 1980
Accounts Submitted 3 Oct 2025
Confirmation Submitted 17 Dec 2025 Next due 28 Dec 2026 6 months remaining
Net assets £38M £2M 2024 year on year
Total assets £38M £2M 2024 year on year
Total Liabilities £0
Charges None No charges registered

Contact & Details

Contact

Registered Address

Organon Pharma (Uk) Limited Shotton Lane Cramlington NE23 3JU United Kingdom

Full company profile for DASHTAG (00090627), an active company based in Cramlington, United Kingdom. Incorporated 31 Oct 1906. Activities of head offices. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type full
Next accounts
Due by

Balance Sheet & P&L (2014–2024)

Cash in Bank

£18.00k

Decreased by £1.61M (-99%)

Net Assets

£38.31M

Decreased by £1.60M (-4%)

Total Liabilities

N/A

Turnover

N/A

Employees

N/A

Debt Ratio

N/A

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (1)

Obs Human Health Holding B.v.
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active 2 Ceased

Organon & Co.

United States Of America

Active
Notified 2 Jun 2021
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors
Ceased

Merck & Co., Inc.

Ceased 2 Jun 2021

Ceased

Group Structure

Group Structure

DASHTAG Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
9 Jun 2026OfficersTermination of John Albert Parsons as director on 31 May 2026
9 Jun 2026OfficersAppointment of Marie-Catherine Barberoux as director on 1 Jun 2026
17 Dec 2025Confirmation StatementConfirmation statement made on 14 Dec 2025 with no updates
3 Oct 2025AccountsAnnual accounts made up to 31 Dec 2024
25 Sept 2025OfficersAppointment of Nicola Barr as director on 1 Sept 2025
9 Jun 2026 Officers

Termination of John Albert Parsons as director on 31 May 2026

9 Jun 2026 Officers

Appointment of Marie-Catherine Barberoux as director on 1 Jun 2026

17 Dec 2025 Confirmation Statement

Confirmation statement made on 14 Dec 2025 with no updates

3 Oct 2025 Accounts

Annual accounts made up to 31 Dec 2024

25 Sept 2025 Officers

Appointment of Nicola Barr as director on 1 Sept 2025

Recent Activity

Latest Activity

Termination of John Albert Parsons as director on 31 May 2026

1 weeks ago on 9 Jun 2026

Appointment of Marie-Catherine Barberoux as director on 1 Jun 2026

1 weeks ago on 9 Jun 2026

Confirmation statement made on 14 Dec 2025 with no updates

6 months ago on 17 Dec 2025

Annual accounts made up to 31 Dec 2024

8 months ago on 3 Oct 2025

Appointment of Nicola Barr as director on 1 Sept 2025

8 months ago on 25 Sept 2025